News
CARL
10.95
+4.89%
0.51
Carlsmed Is Maintained at Buy by Truist Securities
Dow Jones · 18h ago
Carlsmed Price Target Cut to $18.00/Share From $20.00 by Truist Securities
Dow Jones · 18h ago
Carlsmed price target lowered to $18 from $20 at Truist
TipRanks · 19h ago
Analysts Offer Insights on Healthcare Companies: ProQR (PRQR), Lexicon Pharmaceuticals (LXRX) and Carlsmed, Inc. (CARL)
TipRanks · 20h ago
Carlsmed, Inc. (CARL) Gets a Buy from Goldman Sachs
TipRanks · 20h ago
Carlsmed to report first-quarter results after market close, host conference call
PUBT · 1d ago
Carlsmed price target lowered to $23 from $24 at BTIG
TipRanks · 2d ago
BTIG Remains a Buy on Carlsmed, Inc. (CARL)
TipRanks · 2d ago
Weekly Report: what happened at CARL last week (0406-0410)?
Weekly Report · 2d ago
Goldman Sachs Sticks to Their Buy Rating for Carlsmed, Inc. (CARL)
TipRanks · 04/08 20:37
Weekly Report: what happened at CARL last week (0330-0403)?
Weekly Report · 04/06 09:07
Carlsmed CEO Cordonnier to present at Needham Virtual Conference
Reuters · 04/01 20:01
Weekly Report: what happened at CARL last week (0323-0327)?
Weekly Report · 03/30 09:07
Weekly Report: what happened at CARL last week (0316-0320)?
Weekly Report · 03/23 09:07
Weekly Report: what happened at CARL last week (0309-0313)?
Weekly Report · 03/16 09:07
Carlsmed Earnings Call Highlights Rapid Growth, Rising Costs
TipRanks · 03/11 00:25
Weekly Report: what happened at CARL last week (0302-0306)?
Weekly Report · 03/09 09:07
Carlsmed CEO and President Michael Cordonnier Disposes of Common Shares
Reuters · 03/04 21:05
Weekly Report: what happened at CARL last week (0223-0227)?
Weekly Report · 03/02 09:07
Carlsmed (CARL) Revenue Growth At 85.9% Tests Bearish Profitability Narratives
Simply Wall St · 02/27 00:37
More
Webull provides a variety of real-time CARL stock news. You can receive the latest news about CARLSMED INC through multiple platforms. This information may help you make smarter investment decisions.
About CARL
Carlsmed, Inc. is a commercial-stage medical technology company providing AI-enabled personalized spine surgery solutions. Its aprevo technology platform offers solutions for the entire surgical workflow, including pre-operative AI-enabled, surgical planning; intra-operative advanced visualization to support precision placement of aprevo interbody implants, and post-operative data collection and insights intended to improve the digital surgical planning process. Its pre-operative planning software utilizes standard-of-care diagnostic imaging and AI-enabled algorithms to develop personalized digital surgical plans and to design aprevo interbody implants for each patient's pathology and vertebral bone topography. Additionally, the aprevo technology platform supports the collection of real-world, post-operative data to inform its digital surgical planning process. Its platform is commercially available in the United States and is indicated for use in lumbar interbody fusion procedures.